Fusion Antibodies (LON:FAB) Trading Down 2% – Time to Sell?

Fusion Antibodies plc (LON:FAB)’s share price traded down 2% during mid-day trading on Tuesday . The stock traded as low as GBX 9.80 ($0.12) and last traded at GBX 10 ($0.13). Approximately 3,455,756 shares changed hands during trading, a decline of 22% from the average daily volume of 4,450,999 shares. The stock had previously closed at GBX 10.20 ($0.13).

Fusion Antibodies Stock Performance

The stock has a market capitalization of £8.75 million, a P/E ratio of -229.43 and a beta of 0.49. The stock’s 50-day simple moving average is GBX 5.61 and its 200 day simple moving average is GBX 4.25. The company has a debt-to-equity ratio of 2.40, a current ratio of 3.87 and a quick ratio of 2.36.

Insider Buying and Selling

In other news, insider Adrian Kinkaid purchased 83,728 shares of the company’s stock in a transaction that occurred on Wednesday, October 16th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £3,349.12 ($4,190.07). 11.39% of the stock is currently owned by insiders.

Fusion Antibodies Company Profile

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services.